ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 128 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $96,496 | -33.8% | 14,087 | +0.3% | 0.00% | 0.0% |
Q2 2023 | $145,699 | +33.2% | 14,050 | +3.9% | 0.00% | 0.0% |
Q1 2023 | $109,417 | -47.2% | 13,525 | +2.7% | 0.00% | -50.0% |
Q4 2022 | $207,412 | +4.2% | 13,169 | +4.0% | 0.00% | 0.0% |
Q3 2022 | $199,000 | +22.8% | 12,665 | +9.0% | 0.00% | 0.0% |
Q2 2022 | $162,000 | -24.3% | 11,615 | -6.4% | 0.00% | 0.0% |
Q1 2022 | $214,000 | +18.9% | 12,413 | +0.5% | 0.00% | +100.0% |
Q4 2021 | $180,000 | -17.4% | 12,357 | +2.3% | 0.00% | -50.0% |
Q3 2021 | $218,000 | – | 12,084 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |